IPCA LABORATORIES
Back to Income Statement
|
IPCA LABORATORIES Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹8,897 Cr | ₹7,662 Cr | ₹6,204 Cr | ₹5,797 Cr | ₹5,395 Cr |
What is the latest Revenue of IPCA LABORATORIES ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹8,897 Cr |
| Mar2025 | ₹7,662 Cr |
| Mar2024 | ₹6,204 Cr |
| Mar2023 | ₹5,797 Cr |
| Mar2022 | ₹5,395 Cr |
How is Revenue of IPCA LABORATORIES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹8,897 Cr | 16.11 | |
| Mar2025 | ₹7,662 Cr | 23.50 | |
| Mar2024 | ₹6,204 Cr | 7.03 | |
| Mar2023 | ₹5,797 Cr | 7.45 | |
| Mar2022 | ₹5,395 Cr | - | |
Compare Revenue of peers of IPCA LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| IPCA LABORATORIES | ₹49,226.7 Cr | -1.5% | -2.3% | 42.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹434,280.0 Cr | -2.4% | -6.2% | 11.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,737.0 Cr | -3.3% | 1.4% | 57.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,129.0 Cr | -4.5% | -4% | 35.9% | Stock Analytics | |
| CIPLA | ₹108,808.0 Cr | -3.6% | -5% | -10.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,170.0 Cr | -0.2% | 2.5% | -3% | Stock Analytics | |
IPCA LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| IPCA LABORATORIES | -1.5% |
-2.3% |
42.8% |
| SENSEX | -2.3% |
-6.6% |
-12% |
You may also like the below Video Courses